Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
DR

Douglas Ringler — 10 Patents

MPMillennium Pharmaceuticals: 8 patents #100 of 771Top 15%
CSCambridge University Technical Services: 2 patents #14 of 191Top 8%
ILIsis Innovation Limited: 2 patents #84 of 501Top 20%
Revere, MA: #12 of 178 inventorsTop 7%
Massachusetts: #12,897 of 88,656 inventorsTop 15%
Overall (All Time): #481,000 of 4,157,543Top 15%
10 Patents All Time
Douglas Ringler has been granted 10 US patents while listed as an inventor at Millennium Pharmaceuticals. The first was granted in 2003 and the most recent in May 2011. Douglas Ringler ranks #481,000 of 4,157,543 US inventors in our database (top 11.6%). Patent records list Douglas Ringler in Revere, MA, US.

Issued Patents All Time

Showing 1–10 of 10 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
7947272 Compositions and methods of tolerizing a primate to an antigen Mark Frewin, Herman Waldmann, Scott Gorman, Geoff S. Hale, Patricia Rao +3 more 2011-05-24
7858326 Method of diagnosis of inflammatory disease using eotaxin antibodies Paul Ponath, Shixin Qin, Walter Newman, Charles Mackay 2010-12-28
7803904 Mucosal vascular addressing and uses thereof Michael Briskin, Dominic Picarella, Walter Newman 2010-09-28
7541443 Anti-CD4 antibodies Mark Frewin, Herman Waldmann, Scott Gorman, Geoff S. Hale, Patricia Rao +3 more 2009-06-02
7423129 Antibodies to human eotaxin Paul Ponath, Shixin Qin, Walter Newman, Charles Mackay 2008-09-09
7402410 Humanized immunoglobulin reactive with α4β7 integrin Paul Ponath, S. Tarran Jones, Walter Newman, Jose Saldanha, Mary M. Bendig 2008-07-22
7285620 Human chemotactic cytokine Paul Ponath, Shixin Qin, Walter Newman, Charles Mackay 2007-10-23 $7,400,000
7265201 Human chemotactic cytokine Paul Ponath, Shixin Qin, Walter Newman, Charles Mackay 2007-09-04 $4,438,000
7147851 Humanized immunoglobulin reactive with α4β7 integrin Paul Ponath, S. Tarran Jones, Walter Newman, Jose Saldanha, Mary M. Bendig 2006-12-12 $22,610,000
6551593 Treatment of Inflammatory bowel disease by inhibiting binding and/or signalling through &agr; 4 &bgr; 7 and its ligands and madcam Dominic Picarella, Walter Newman 2003-04-22 $50,304,000